Results 161 to 170 of about 21,464 (182)

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management

American Journal of Hematology, 2020
Ayalew Tefferi, Tiziano Barbui
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Paola Guglielmelli
exaly  

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Cancer Cell, 2005
Jan Cools, Benjamin L Ebert, Gerlinde Wernig   +2 more
exaly  

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

Leukemia, 2017
Francesco Passamonti, Toni Giorgino, Paola Guglielmelli   +2 more
exaly  

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Blood, 2007
Attilio Orazi, Giovanni Barosi, Gunnar Birgegard   +2 more
exaly  

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

Leukemia, 2009
Ayalew Tefferi
exaly  

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Blood, 2012
Tiziano Barbui, Alessandra Carobbio, Francesco Passamonti   +2 more
exaly  

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Blood Cancer Journal, 2015
Ayalew Tefferi
exaly